[
  {
    "ts": null,
    "headline": "BrightHeart Announces Voluson™ Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam",
    "summary": "PARIS, February 05, 2026--BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare’s Voluson™ Solution Store, bringing advanced AI support directly into routine prenatal care. The addition of this AI platform to the Voluson Solution store is poised to improve early detection of congenital defects, reduce diagnostic uncertainty, and ultimately support better outcomes for clinicians, expectant parents and their",
    "url": "https://finnhub.io/api/news?id=2ea15915c23fba1b0ddd6663c8e8415d443aade5c4110366b16bfaaab38b6283",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770300180,
      "headline": "BrightHeart Announces Voluson™ Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam",
      "id": 138364670,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "PARIS, February 05, 2026--BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare’s Voluson™ Solution Store, bringing advanced AI support directly into routine prenatal care. The addition of this AI platform to the Voluson Solution store is poised to improve early detection of congenital defects, reduce diagnostic uncertainty, and ultimately support better outcomes for clinicians, expectant parents and their",
      "url": "https://finnhub.io/api/news?id=2ea15915c23fba1b0ddd6663c8e8415d443aade5c4110366b16bfaaab38b6283"
    }
  },
  {
    "ts": null,
    "headline": "Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results",
    "summary": "Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty. Claim 50% Off TipRanks Pr",
    "url": "https://finnhub.io/api/news?id=cfaad9cb9c8162fc497e630737dd9f08ad8a09c9963d03c6eb09d779786d0bd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770300052,
      "headline": "Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results",
      "id": 138363701,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty. Claim 50% Off TipRanks Pr",
      "url": "https://finnhub.io/api/news?id=cfaad9cb9c8162fc497e630737dd9f08ad8a09c9963d03c6eb09d779786d0bd9"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare Technologies Pops, And The Upside Isn't Over Yet",
    "summary": "GE HealthCare's key growth drivers include the Imaging and Pharmaceutical Diagnostics segments. Read why maintaining Buy rating for GEHC stock is appropriate.",
    "url": "https://finnhub.io/api/news?id=f73aa8e01a8d8a3588ac96a410b7c58164b317ca2dcbb5f88e8e8ebbcc6b79e7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770275400,
      "headline": "GE HealthCare Technologies Pops, And The Upside Isn't Over Yet",
      "id": 138363010,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1469615492/image_1469615492.jpg?io=getty-c-w1536",
      "related": "GEHC",
      "source": "SeekingAlpha",
      "summary": "GE HealthCare's key growth drivers include the Imaging and Pharmaceutical Diagnostics segments. Read why maintaining Buy rating for GEHC stock is appropriate.",
      "url": "https://finnhub.io/api/news?id=f73aa8e01a8d8a3588ac96a410b7c58164b317ca2dcbb5f88e8e8ebbcc6b79e7"
    }
  },
  {
    "ts": null,
    "headline": "GEHC Q4 Deep Dive: Product Pipeline and Service Recurring Revenue Drive Outlook",
    "summary": "Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.1% year on year to $5.70 billion. Its non-GAAP profit of $1.44 per share was 3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=b81c6f34f57f372083d50c1cc47c21faa9abf4f206bdbd4e6b11383dff90e43d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770269705,
      "headline": "GEHC Q4 Deep Dive: Product Pipeline and Service Recurring Revenue Drive Outlook",
      "id": 138362821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.1% year on year to $5.70 billion. Its non-GAAP profit of $1.44 per share was 3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=b81c6f34f57f372083d50c1cc47c21faa9abf4f206bdbd4e6b11383dff90e43d"
    }
  },
  {
    "ts": null,
    "headline": "Is GE HealthCare Technologies (GEHC) Offering Value After Recent Share Price Weakness",
    "summary": "If you are wondering whether GE HealthCare Technologies is priced attractively right now or if the current share price already reflects its potential, this article walks you through what the numbers are saying about value. The stock last closed at US$82.58, with returns of 4.2% over the past week, a 2.9% decline over the last 30 days, a 0.3% decline year to date, and a 5.1% decline over the past year, while the 3 year return sits at 18.3%. Recent attention on GE HealthCare has been supported...",
    "url": "https://finnhub.io/api/news?id=ca8d372cebe500ce0b91c8aa1ddfb40695a10005a16ae997b9df412927dac213",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770257465,
      "headline": "Is GE HealthCare Technologies (GEHC) Offering Value After Recent Share Price Weakness",
      "id": 138360523,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "If you are wondering whether GE HealthCare Technologies is priced attractively right now or if the current share price already reflects its potential, this article walks you through what the numbers are saying about value. The stock last closed at US$82.58, with returns of 4.2% over the past week, a 2.9% decline over the last 30 days, a 0.3% decline year to date, and a 5.1% decline over the past year, while the 3 year return sits at 18.3%. Recent attention on GE HealthCare has been supported...",
      "url": "https://finnhub.io/api/news?id=ca8d372cebe500ce0b91c8aa1ddfb40695a10005a16ae997b9df412927dac213"
    }
  }
]